Sublime

Dallas-based Colossal Biosciences, the self-described de-extinction company behind the woolly mammoth and thylacine, today announced that it is spinning off Form Bio, as an independent software company offering a computational life sciences platform that bridges the gap between data and discovery. 

HOLY SHIT IT'S HAPPENING AI can now write genomes from scratch. Arc Institute an NVIDIA just published Evo-2, the largest AI model for biology, trained on 9.3 trillion DNA base pairs spanning the entire tree of life. it doesn’t just analyze genomes. it creates them___LINEBREAK_... See more

Super excited to officially launch our newest product line -- Ginkgo Automation!🤖🧬🤖 Over the past 10 years @Ginkgo has built a ton of amazing technologies from automation to long DNA construction to complex -omics to proprietary data and AI assets. These tools had been kept in-house and o... See more

AI told me the diseases I was at risk of based on modern medical research from my raw genome sequence. Genealogy companies don't provide this data because of FDA regulation risk. o3 went through ~15MB of raw data in 4mins. A country of geniuses in a datacenter. H... See more

After 2+ years heads down, I'm thrilled to unveil what I've been building with @aryelipman! @biosphereio, we're unleashing biomanufacturing with a breakthrough UV-sterilized reactor that will slash the cost of producing abundant and sustainable chemicals and food at world scale. We're backed by $8.8m in financing led by @lowercarbon and VXI, with ... See more

Published on bioRxiv - the world's first 100M single cell dataset! Tahoe-100M includes 52,886 unique drug perturbations and was run through Parse’s GigaLab in < 1 month! https://t.co/kutCWtOfQI